IRWD Earnings
Latest Revenue113.0M
Latest Net Income51.3M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.31 | 113.0M | 51.3M | +32.6% | +106.7% |
| Q1 2026 | $0.25 | 106.5M | 40.8M | +158.9% | +208.7% |
| Q4 2025 | -$0.01 | 47.7M | -2276000 | -47.3% | -200.0% |
| Q3 2025 | $0.25 | 122.1M | 40.1M | +33.3% | +1,150.0% |
| Q2 2025 | $0.15 | 85.2M | 23.6M | -9.7% | +1,600.0% |
| Q1 2025 | -$0.23 | 41.1M | -37386000 | -45.1% | -666.7% |
| Q4 2024 | $0.01 | 90.5M | 2.3M | -23.0% | +200.0% |
| Q3 2024 | $0.02 | 91.6M | 3.6M | -19.5% | -80.0% |
| Q2 2024 | -$0.01 | 94.4M | -860000 | — | — |
| Q1 2024 | -$0.03 | 74.9M | -4162000 | — | — |
| Q4 2023 | -$0.01 | 117.6M | -1745000 | — | — |
| Q3 2023 | $0.10 | 113.7M | 13.9M | — | — |
Ironwood Pharmaceuticals, Inc. - (IRWD) — Earnings